Perrigo | PRGO - Current Liabilities


Perrigo reported $1.02B in Current Liabilities for its fiscal quarter ending in September of 2026.





Current Liabilities Change Date
AbbVie USD 43.1B 1.46B Sep/2026
Abbott USD 16.15B 1.66B Sep/2026
Bayer EUR 29.4B 2.87B Sep/2026
Bristol-Myers Squibb USD 18.75B 94M Sep/2026
Coherus Biosciences USD 75.51M 56.82M Jun/2026
Corcept Therapeutics USD 177.68M 23.87M Sep/2026
Dr.Reddys Laboratories INR 154.3B 3.04B Sep/2026
Eli Lilly USD 47B 745M Sep/2026
J&J USD 55.46B 562M Sep/2026
Merck USD 28.8B 1.07B Sep/2026
Nestle CHF 45.29B 4.6B Jun/2026
Pacira USD 126.1M 4.08M Sep/2026
Perrigo USD 1.02B 34.4M Sep/2026
Pfizer USD 31.73B 920M Sep/2026
Phibro Animal Health USD 295.79M 20.68M Sep/2026
Prestige Brands USD 168.5M 14.7M Sep/2026
Reckitt Benckiser GBP 7.94B 901M Dec/2024
Sanofi EUR 29.77B 2.16B Sep/2026
Supernus Pharmaceuticals USD 285.4M 61.98M Sep/2026
Teva Pharmaceutical Industries USD 15.42B 221M Sep/2026
Xeris Pharmaceuticals USD 134.48M 55.09M Sep/2026
Zoetis USD 2.68B 621M Sep/2026